Correction to Design and Synthesis of Orally Bioavailable

Search; Citation; Subject .... to Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase Inhibitors .... Article I...
0 downloads 0 Views 114KB Size
Correction pubs.acs.org/acsmedchemlett

Correction to Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase Inhibitors Sharadha Subramanian, Abran Costales, Teresa E. Williams, Barry Levine, Christopher M. McBride, Daniel Poon, Payman Amiri, Paul A. Renhowe, Cynthia M. Shafer, Darrin Stuart, Joelle Verhagen, and Savithri Ramurthy* ACS Med. Chem. Lett. 2014, 5 (9), 989−992. DOI: 10.1021/ml5002272 The error is on page 990 in Table 1. Compound 11 should be 3-OCF3, and compound 16 should be 4-OCF3.

© XXXX American Chemical Society

A

dx.doi.org/10.1021/ml500461g | ACS Med. Chem. Lett. XXXX, XXX, XXX−XXX